Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)

NCT03163277 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Sloww accrual and COVID-19 related problems (impossible to perform LPs)

Conditions

Hiv
Neurocognitive Dysfunction

Interventions

DRUG: emtricitabine, darunavir/cobicistat, maraviroc

Sponsor

Giovanni Di Perri